IDO is overexpressed in some cancer cells and functions as an enzyme that catalyses the degradation of essential amino acid tryptophan (Trp) and accumulation of its metabolites18, 19, resulting in cell cycle arrest and death of effector T cells, but increases in the number of regulatory T cells20. Here, IDO1 is linked to cancer.